Table 2.

CNAs associated with the parameters latency, gender and dose

Test parameter	Groups	n	Gains	Losses
Latency	<17 years	47	3	3
	≥17 years	37	174	36
Gender	Female	51	73	1
	Male	33	—	—
Latency (females)	<17 years	27	3	—
	≥17 years	24	162	45
Dose	≤300 mGy	40	—	—
	301–1000 mGy	18	28	—
	>1000 mGy	26	—	—